Sclérodermie systémique

Sclérodermie systémique

  
Moinzadeh P et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2015 Apr;74(4):730-7.Lire le résumé
Bernstein EJ et al. Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study. Arthritis Rheumatol. 2015 May;67(5):1314-22.Lire le résumé
Avouac J et al. Cardiac Biomarkers in Systemic Sclerosis: Contribution of High-Sensitivity Cardiac Troponiin in Addition to N-Terminal Pro-Brain Natriuretic Peptide. Arthritis Care Res (Hoboken). 2015 Jul;67(7):1022-30.Lire le résumé
Wirz EG et al. ; EUSTAR coauthors. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis. 2015 Jul 31.Lire le résumé
Paik JJ et al. Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness. Arthritis Care Res (Hoboken). 2015 Oct;67(10):1416-25Lire le résumé
Avouac J et al. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.Arthritis Care Res (Hoboken). J Rheumatol. 2015 Oct;42(10):1801-7.Lire le résumé
Nagaraja V et al ; Old medications and new targeted therapies in systemic sclerosis. Rheumatology (Oxford). 2015 Nov;54(11):1944-53Lire le résumé
Suliman YA et al. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease. Arthritis Rheumatol. 2015 Dec;67(12):3256-61Lire le résumé
Avouac J et al. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. janv 2016;75(1):103‑9.Lire le résumé
Mihai C et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis. avr 2016;75(4):681‑6.Lire le résumé
Hurabielle C et al. Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease. Arthritis Care Res. juill 2016;68(7):1021‑7.Lire le résumé
Stamm A et al. Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis. Eur Respir J. 6 oct 2016 Lire le résumé
Daoussis D et al. A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease. Semin Arthritis Rheum. 2017 Apr;46(5):625-631Lire le résumé
Hoffmann-Vold A-M et al. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort. J Rheumatol. 2017 Jan 15 Lire le résumé
Herrick et al. “Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis: The European Scleroderma Observational Study (ESOS).” Annals of the Rheumatic Diseases, February 10, 2017.Lire le résumé
Sanges S et al. Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature. Autoimmun Rev. 13 févr 2017.Lire le résumé
Man A et al. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis. Ann Rheum Dis. 2017 Feb 17.Lire le résumé
Goh NS et al. Short term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol Hoboken NJ. 2017 Apr 20Lire le résumé
Volkmann ER et al. Mycophenolate versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II. Arthritis Rheumatol Hoboken NJ. 4 avr 2017Lire le résumé
Andracco R et al. The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score. Arthritis Res Ther. 2017 Jun 13;19(1):133Lire le résumé
Vigone B et al. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study. Arthritis Res Ther. 2017 Jun 20;19(1):145.Lire le résumé
Le Gouellec N et al. Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease. PloS One.
2017;12(8):e0181692.
Lire le résumé
Gaine S et al. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Eur Respir J. 2017 Aug;50(2).Lire le résumé
Eyraud A et al. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: A systematic review of literature. Br J Dermatol. 2017 Sep 14Lire le résumé
Martis N et al. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing. J Rheumatol. 2017 Nov 1Lire le résumé
Sullivan KM. et al. Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 2018;378:35-47. Lire le résumé
Khanna D. et al. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Ann Rheum Dis. 2018;77:212–220.Lire le résumé
Herrick AL et al. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. (in press).Lire le résumé
Coghlan G, Wolf M, Distler O, et al. Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis. Eur Respir J 2018 Lire le résumé
TThiebaut M, Launay D, Rivière S, Mahévas T, Bellakhal S, Hachulla E, et al. Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review. Autoimmun Rev 2018Lire le résumé
Igusa Igusa TT, Hummers LK, Visvanathan K, Richardson C, Wigley FM, Casciola-Rosen L, Rosen A, Shah AA. Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Ann Rheum Dis. 2018 Apr 20.Lire le résumé
Jaeger VK, Valentini G, Hachulla E, Cozzi F, Distler O, Airó P, et al. Smoking in Systemic Sclerosis: a Longitudinal European Scleroderma Trials and Research Group Study. Arthritis & Rheumatology (Hoboken, NJ). 2018 May 21; Lire le résumé
Jouvray M, Launay D, Dubucquoi S, Sobanski V, Podevin C, Lambert M, et al. Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis. JAMA Dermatology. 2018 Jul 1;154(7):796,Lire le résumé
Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, et al. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model. Annals of the Rheumatic Diseases. 2018 Sep;77(9):1326–32Lire le résumé
Guler SA, Winstone TA, Murphy D, Hague C, Soon J, Sulaiman N, et al. Does Systemic Sclerosis-Associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression. Annals of the American Thoracic Society [Internet]. 2018 Sep 6 [cited 2018 Sep 26]; Available from: https://www.atsjournals.org/doi/10.1513/AnnalsATS.201806-362OCLire le résumé
Tennøe AH, Murbræch K, Andreassen JC, Fretheim H, Garen T, Gude E, et al. Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis. Journal of the American College of Cardiology. 2018 Oct;72(15):1804–13. Lire le résumé
Champtiaux N, Cottin V, Chassagnon G, Chaigne B, Valeyre D, Nunes H, et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. Seminars in Arthritis and Rheumatism [Internet]. 2018 Oct [cited 2018 Nov 26]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0049017217305115 Lire le résumé
Lescoat A, Yelnik CM, Coiffier G, Wargny M, Lamotte C, Cazalets C, et al. Ulnar Artery Occlusion and severity markers of vasculopathy in Systemic sclerosis: a multicenter cross‐sectional study. Arthritis & Rheumatology [Internet]. 2018 Dec 15 [cited 2018 Dec 19]Lire le résumé
Nagel C, Marra AM, Benjamin N, Blank N, Cittadini A, Coghlan G, et al. Reduced right ventricular output reserve in patients with systemic sclerosis and mildly elevated pulmonary arterial pressures. Arthritis & Rheumatology [Internet]. 2019 Jan 7 [cited 2019 Jan 21]; Available from: http://doi.wiley.com/10.1002/art.40814Lire le résumé
Young A, Vummidi D, Visovatti S, Homer K, Wilhalme H, White ES, et al. Prevalence, Treatment and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis. Arthritis & Rheumatology [Internet]. 2019 Feb 14 [cited 2019 Feb 18]; Available from: http://doi.wiley.com/10.1002/art.40862Lire le résumé